Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl
Renae A Lloyd, Elizabeth Hotham, Catherine Hall, et al.
Pain Medicine (2016) Vol. 18, Iss. 12, pp. 2369-2387
Open Access | Times Cited: 23

Showing 23 citing articles:

Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review
Shao-Cheng Wang, Yuan‐Chuan Chen, Chun-Hung Lee, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4294-4294
Open Access | Times Cited: 106
Update of the Scientific Opinion on opium alkaloids in poppy seeds
Helle Katrine Knutsen, Jan Alexander, Lars Barregård, et al.
EFSA Journal (2018) Vol. 16, Iss. 5
Open Access | Times Cited: 62
The Role of Pharmacogenomics in Opioid Prescribing
Aaron Wong, Andrew A. Somogyi, Justin P. Rubio, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 10, pp. 1353-1369
Open Access | Times Cited: 22
Effects of Opioids in Cancer Pain: An Interplay Among Genetic Factors, Immune Response, and Clinical Outcomes—A Scoping Review
Kamil Adamczyk, Konrad Zuzda, Miłosz Jankowski, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 863-863
Open Access
Predicting and Understanding the Human Microbiome’s Impact on Pharmacology
Reese Hitchings, Libusha Kelly
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 7, pp. 495-505
Open Access | Times Cited: 42
<em>CYP2D6</em> genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort
Concetta Dagostino, Massimo Allegri, Valerio Napolioni, et al.
Pharmacogenomics and Personalized Medicine (2018) Vol. Volume 11, pp. 179-191
Open Access | Times Cited: 38
OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study
Kwo Wei David Ho, Margaret R. Wallace, Roland Staud, et al.
The Pharmacogenomics Journal (2019) Vol. 20, Iss. 3, pp. 471-481
Open Access | Times Cited: 26
Severe Pain in Chronic Pancreatitis Patients: Considering Mental Health and Associated Genetic Factors
Ellyn Dunbar, Jami L. Saloman, Anna Evans Phillips, et al.
Journal of Pain Research (2021) Vol. Volume 14, pp. 773-784
Open Access | Times Cited: 21
Genome-wide association reveals a locus in neuregulin 3 associated with gabapentin efficacy in women with chronic pelvic pain
Scott C. Mackenzie, Nilüfer Rahmioğlu, Liana Romaniuk, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110370-110370
Open Access | Times Cited: 2
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain
Federica De Rosa, Bruno Giannatiempo, Bruno Charlier, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2088-2088
Open Access | Times Cited: 6
Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments
Eloy Almenar‐Pérez, Teresa Sánchez-Fito, Tamara Ovejero, et al.
Pharmaceutics (2019) Vol. 11, Iss. 3, pp. 126-126
Open Access | Times Cited: 17
Exploring the Role of Bergamot Polyphenols in Alleviating Morphine-Induced Hyperalgesia and Tolerance through Modulation of Mitochondrial SIRT3
Sara Ilari, Saverio Nucera, Lucia Carmela Passacatini, et al.
Nutrients (2024) Vol. 16, Iss. 16, pp. 2620-2620
Open Access | Times Cited: 1
Acute pain and side effects after tramadol in breast cancer patients: results of a prospective double-blind randomized study
Nikola Bešić, Jaka Smrekar, Branka Stražišar
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking back on Treatments
Eloy Almenar‐Pérez, Teresa Sánchez-Fito, Tamara Ovejero, et al.
(2019)
Open Access | Times Cited: 10
Efficacy and Safety of Opioid Therapy Guided by Pharmacogenetics: A Systematic Review
Federico Rodríguez Cairoli, Francisco Appiani, Juan M. Sambade, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 9, pp. 573-586
Closed Access | Times Cited: 6
A potential paradigm shift in opioid crisis management: The role of pharmacogenomics
David Eapen-John, Ayeshah G. Mohiuddin, James L. Kennedy
The World Journal of Biological Psychiatry (2021) Vol. 23, Iss. 6, pp. 411-423
Open Access | Times Cited: 4
Chronic Post-thoracotomy Pain
Peter MacDougall
Springer eBooks (2019), pp. 1045-1057
Closed Access | Times Cited: 3
Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease
Nyasha Lorraine Mapira, Roslyn Thelingwani, Zedias Chikwambi, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 7, pp. 359-369
Open Access | Times Cited: 1
Exploring the use of extended release opioids at shortened dosing intervals in people with chronic pain and high risk medication or substance use
Laura Murphy, Bruna Brands, Daniel Grant, et al.
International Journal of Clinical Pharmacy (2020) Vol. 43, Iss. 2, pp. 404-410
Closed Access | Times Cited: 2
Effect of gene variants on opioid dose, pain and adverse effect outcomes in advanced cancer: an explorative study
Aaron Wong, Pål Klepstad, Andrew A. Somogyi, et al.
Pharmacogenomics (2009) Vol. 24, Iss. 18, pp. 901-913
Closed Access | Times Cited: 1
Arzneimitteltherapiesicherheit und besondere Verfahren

Elsevier eBooks (2018), pp. 971-1009
Closed Access
Interindividual variability in diabetic patients’ response to opium poppy: an overview of impressive factors
Fatemeh Hendijani, Fatemeh Sadat Hosseini
Personalized Medicine (2022) Vol. 19, Iss. 2, pp. 155-163
Closed Access
Arzneimitteltherapiesicherheit und besondere Verfahren

Elsevier eBooks (2022), pp. 1071-1113
Closed Access
Page 1

Scroll to top